These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 27793157)

  • 1. Integrating a prospective pilot trial and patient-derived xenografts to trace metabolic changes associated with acute myeloid leukemia.
    Carrabba MG; Tavel L; Oliveira G; Forcina A; Quilici G; Nardelli F; Tresoldi C; Ambrosi A; Ciceri F; Bernardi M; Vago L; Musco G
    J Hematol Oncol; 2016 Oct; 9(1):115. PubMed ID: 27793157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients.
    Hoang VT; Buss EC; Wang W; Hoffmann I; Raffel S; Zepeda-Moreno A; Baran N; Wuchter P; Eckstein V; Trumpp A; Jauch A; Ho AD; Lutz C
    Int J Cancer; 2015 Aug; 137(3):525-36. PubMed ID: 25545165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum metabonomics of acute leukemia using nuclear magnetic resonance spectroscopy.
    Musharraf SG; Siddiqui AJ; Shamsi T; Choudhary MI; Rahman AU
    Sci Rep; 2016 Aug; 6():30693. PubMed ID: 27480133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation and prognostic stratification of acute myeloid leukemia by serum-based spectroscopy coupling with metabolic fingerprints.
    Duan Z; Chen Y; Ye M; Xiao L; Chen Y; Cao Y; Peng Y; Zhang J; Zhang Y; Yang T; Liu W; Feng S; Hu J
    FASEB J; 2022 Jul; 36(7):e22416. PubMed ID: 35713583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Untargeted metabolomics of newborn dried blood spots reveals sex-specific associations with pediatric acute myeloid leukemia.
    Petrick L; Imani P; Perttula K; Yano Y; Whitehead T; Metayer C; Schiffman C; Dolios G; Dudoit S; Rappaport S
    Leuk Res; 2021 Jul; 106():106585. PubMed ID: 33971561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional heterogeneity of genetically defined subclones in acute myeloid leukemia.
    Klco JM; Spencer DH; Miller CA; Griffith M; Lamprecht TL; O'Laughlin M; Fronick C; Magrini V; Demeter RT; Fulton RS; Eades WC; Link DC; Graubert TA; Walter MJ; Mardis ER; Dipersio JF; Wilson RK; Ley TJ
    Cancer Cell; 2014 Mar; 25(3):379-92. PubMed ID: 24613412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiling three-dimensional nuclear telomeric architecture of myelodysplastic syndromes and acute myeloid leukemia defines patient subgroups.
    Gadji M; Adebayo Awe J; Rodrigues P; Kumar R; Houston DS; Klewes L; Dièye TN; Rego EM; Passetto RF; de Oliveira FM; Mai S
    Clin Cancer Res; 2012 Jun; 18(12):3293-304. PubMed ID: 22539801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study.
    Steensma DP; Abedi M; Bejar R; Cogle CR; Foucar K; Garcia-Manero G; George TI; Grinblatt D; Komrokji R; Ma X; Maciejewski J; Pollyea DA; Savona MR; Scott B; Sekeres MA; Thompson MA; Swern AS; Nifenecker M; Sugrue MM; Erba H
    BMC Cancer; 2016 Aug; 16():652. PubMed ID: 27538433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative receptor tyrosine kinases and anti-apoptotic transcripts hold potential for predicting inferior outcome in adult acute myeloid leukemia: a prospective pilot study.
    Sharawat SK; Vishnubhatla S; Bakhshi R; Raina V; Kumar L; Sharma A; Bakhshi S
    Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):501-508.e2. PubMed ID: 25065779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Azacytidine treatment for relapsed or refractory acute myeloid leukemia after intensive chemotherapy.
    Ivanoff S; Gruson B; Chantepie SP; Lemasle E; Merlusca L; Harrivel V; Charbonnier A; Votte P; Royer B; Marolleau JP
    Am J Hematol; 2013 Jul; 88(7):601-5. PubMed ID: 23619977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
    Lu C; Hassan HT
    Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Experimental and Computational Protocol to Study Cell Proliferation in Human Acute Myeloid Leukemia Xenografts.
    Vlachou T; Nobile MS; Ronchini C; Besozzi D; Pelicci PG
    Methods Mol Biol; 2021; 2185():241-258. PubMed ID: 33165852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiocidin induces differentiation of acute myeloid leukemia cells.
    Tuszynski GP; Rothman VL
    Exp Mol Pathol; 2013 Dec; 95(3):249-54. PubMed ID: 24036285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive analysis of primary acute myeloid leukemia identifies biomarkers predicting susceptibility to human allogeneic Vγ9Vδ2 T cells.
    Gundermann S; Klinker E; Kimmel B; Flierl U; Wilhelm M; Einsele H; Kunzmann V
    J Immunother; 2014; 37(6):321-30. PubMed ID: 24911793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current and emerging therapies for acute myeloid leukemia.
    Robak T; Wierzbowska A
    Clin Ther; 2009; 31 Pt 2():2349-70. PubMed ID: 20110045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SUMOylation of sPRDM16 promotes the progression of acute myeloid leukemia.
    Dong S; Chen J
    BMC Cancer; 2015 Nov; 15():893. PubMed ID: 26559765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An extensive pharmacokinetic, metabolic and toxicological review of elderly patients under intensive chemotherapy for acute myeloid leukemia.
    Kaur I; Constance JE; Kosak KM; Spigarelli MG; Sherwin CM
    Expert Opin Drug Metab Toxicol; 2015 Jan; 11(1):53-65. PubMed ID: 25488904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomic profiling of drug responses in acute myeloid leukaemia cell lines.
    Tiziani S; Lodi A; Khanim FL; Viant MR; Bunce CM; Günther UL
    PLoS One; 2009; 4(1):e4251. PubMed ID: 19158949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot study of erlotinib in patients with acute myeloid leukemia.
    Sayar H; Czader M; Amin C; Cangany M; Konig H; Cripe LD
    Leuk Res; 2015 Feb; 39(2):170-2. PubMed ID: 25498508
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.